Early detection of melanoma is key to preventing and treating skin cancer. When removed promptly and early on, skin cancer is more likely to be cured. Goldenberg Dermatology NYC proudly features Nevisense, an advanced method utilized for the detection of melanoma and abnormal moles (dysplastic nevi) in the earliest stages. The FDA-approved treatment method employs Electrical Impedance Spectroscopy (EIS) to discover malignant lesions at a cellular level. At their New York office, Dr. Gary Goldenberg and Dr. Kristina Goldenberg are pleased to offer this non-invasive procedure to safely and accurately study atypical lesions in their patients.
Many dermatologists offer surface examinations for advanced melanomas and non-malignant lesions, but Goldenberg Dermatology is the first in the United States and NY to feature Nevisense. By combining visual examination and dermoscopy, our physicians can also use this advanced technology to thoroughly examine abnormal cells with this procedure. Nevisense is designed to detect atypical lesions and early-stage melanomas, improving diagnostic accuracy and potentially preventing unnecessary biopsies. This precise procedure is comfortable, non-invasive, and highly accurate. Discovering abnormal nevi early can potentially save lives and prevent the progression of these lesions to melanoma.